Bionik Laboratories Corp. (BNKL)
| Market Cap | 1.26K |
| Revenue (ttm) | 1.81M +41.7% |
| Net Income | -4.95M |
| EPS | -0.72 |
| Shares Out | 12.59M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 578 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | 0.000001 - 0.0001 |
| Beta | 51.75 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Bionik Laboratories
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Co... [Read more]
News
Bionik Laboratories Granted United States Patent for Innovative Rehabilitation Technology
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (“Bionik” or the “Company”), a robotics company providing neurological functional recovery solutions to stroke survivors and others with mobility cha...
Bionik Laboratories Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others w...
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility ...
Bionik Laboratories Enters into Distribution Agreement with Pro-Med Technology for the Sale of InMotion® Robotic Devices in Hong Kong
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility ...
Bionik Laboratories' InMotion® Robotic Devices on Display at the Korea International Medical & Hospital Equipment Show (KIMES)
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility ...
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility ...
Bionik Laboratories Reports Second Quarter Fiscal Year 2023 Financial Results
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL), a robotics company providing neurological functional recovery solutions to stroke survivors and others with functional and mobility ...
Bionik Laboratories to Present at the Q4 Virtual Investor Summit
Presentation to be Webcast at 9:00 AM (ET), Monday, November 14, 2022
Bionik Laboratories Appoints Richard Russo, Jr. as Chief Executive Officer and Dan Gonsalves as Chief Financial Officer
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK:BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others wi...
Bionik Laboratories Acquires Florida Rehabilitation Center; First in Strategic National Rollout
BOSTON--(BUSINESS WIRE)--Bionik Laboratories Corp. (OTCPINK: BNKL) ("Bionik" or the "Company"), a robotics company providing neurological functional recovery solutions to stroke survivors and others w...
BIONIK Laboratories to Present at National Investment Banking Association Conference
Company focused on delivering long term value for investors BOSTON, MA / ACCESSWIRE / September 1, 2022 / BIONIK Laboratories Corp. (OTC PINK:BNKL) ("BIONIK" or the "Company"), a robotics company focu...
BIONIK Laboratories Reports First Quarter Financial Results
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobi...
BIONIK Laboratories Corp. to Present at Investor Summit Group's Q3 Virtual Conference
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTC Pink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobi...
BIONIK Laboratories Announces the Sale & Installation of a New InMotion® ARM/HAND Robotic Device to Tampa General Hospital for its Rehabilitation Center
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke surviv...
BIONIK Laboratories Reports Fourth Quarter and Fiscal Year 2022 Financial Results
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCPink: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobil...
BIONIK Laboratories: Strong Sales Pipeline Delivering Hope to Stroke Survivors
As BIONIK Laboratories (BNKL) marks National Stroke Awareness Month, Interim CEO, Richard Russo, talks about what's next for the companyNew York, New York--(Newsfile Corp. - May 25, 2022) - PCG Digita...
BIONIK Laboratories to Attend the 2022 American Occupational Therapy Association (AOTA) Conference & Expo
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to stroke surviv...
BIONIK Laboratories Reports 15-20% Increase in Therapeutic Gains on InMotion® Robotic Devices in New Patient Outcomes Data Report
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals wi...
BIONIK Laboratories Reports Third Quarter Fiscal Year 2022 Financial Results
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological and mobilit...
BIONIK Laboratories to Participate at the American Physical Therapy Association Conference
BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals w...
BIONIK Laboratories InMotion® Robotics Technology Meets the Recovery Demands from an Increase of Stroke Patients Brought on by Severe Cases of COVID-19
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to ind...
BIONIK Laboratories to Participate at MEDICA, a Leading International Trade Show for the Medical Industry
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) (“BIONIK” or the “Company”), a robotics company focused on providing rehabilitation and assistive technology solutions to ind...
BIONIK Laboratories Reports Second Quarter Fiscal Year 2022 Financial Results
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL), a robotics company focused on providing rehabilitation and assistive technology solutions to individuals with neurological an...
BIONIK Laboratories Announces Commercial Team Addition With Newly Hired Regional Sales Director, Tony Bellofatto
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB: BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to ind...
BIONIK Laboratories Reports a 72% Increase in Patient Sessions on its InMotion® Robotic Devices Since Launch of InMotion Connect™ Platform
TORONTO & BOSTON--(BUSINESS WIRE)--BIONIK Laboratories Corp. (OTCQB:BNKL) ("BIONIK" or the "Company"), a robotics company focused on providing rehabilitation and assistive technology solutions to indi...